Fig. 14
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-BET inhibitor
From: Recent developments in epigenetic cancer therapeutics: clinical advancement and emerging trends

Design of dual HDAC-BET inhibitor